Financial News Archive

# FDA Approves Generic Tofacitinib from Novadoz Pharmaceuticals Novadoz Pharmaceuticals LLC has received FDA approval for its generic tofacitinib cit...

Sun Pharmaceutical Industries has received FDA approval for its generic tofacitinib citrate oral formulation, a regulatory milestone expected to drive...

Breckenridge Pharmaceutical’s FDA approval for oral tofacitinib citrate is set to introduce aggressive competition to the branded market, likely press...

Aurobindo Pharma received FDA approval for its generic tofacitinib citrate oral tablets on June 3, 2026, establishing a new entrant in the JAK inhibit...

Novadoz Pharmaceuticals secured FDA approval June 3, 2026, for oral Tofacitinib Citrate tablets, positioning the firm to capitalize on a significant r...

SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnos...

Apotex has secured FDA approval for the generic version of tofacitinib (ANDA218096), slated for release on June 3, 2026, which is set to intensify com...

BriaCell Therapeutics filed a warrant agreement allowing placement agents to purchase common shares starting June 2, 2026, expiring five years later p...

Dorman Products commenced a private offering of $450 million in senior notes due 2034 to qualified institutional buyers, with proceeds designated for ...

Hallmark Venture Group assigned its promissory note from Traderverse Inc., which had a December 2025 balance of approximately $113,752 and was already...

Nauticus Robotics executed a third amendment to its loan agreement, modifying lender obligations and stockholder voting rights capped at 4.99% ownersh...

News Corporation announced a buyback program authorizing repurchase of up to $1 billion in aggregate of the company's Class A common stock. The share ...

Champion Homes announced leadership appointments of Wade Lyall as Chief Sales Officer, John Kastanek as Chief Customer Experience Officer, and Andrew ...

Nuo Therapeutics issued interim common stock purchase warrants dated May 29, 2026, exercisable through January 23, 2031, in connection with a Loan and...

NRx Pharmaceuticals announced a proposed underwritten public offering of common stock with BTIG and Lucid Capital Markets as lead bookrunners. The com...

i3 Verticals filed a presentation for Q2 fiscal year 2026 containing financial performance details and forward-looking statements. The filing includes...

Orgenesis Inc. submitted an amended certificate of incorporation to the SEC as part of routine corporate governance documentation. The filing reflects...

Xometry, Inc. is conducting a secondary offering of 2,647,059 shares of Class A Common Stock with underwriters J.P. Morgan and Goldman Sachs, with an ...

Whirlpool upsized its offering of Senior Secured Second Lien Notes to $2 billion across two tranches maturing in 2031 and 2034, with rates of 7.500% a...

NKGen Biotech amended its secured convertible loan agreement to receive $2.42 million in additional funding from AlpineBrook Capital, with new warrant...